By the summer of 2026, every major investment newsletter publisher was running a promo built on the same structural hook: a private company you can get into before it goes public. Jeff Brown pitched a public proxy stock holding billions in Anthropic equity. Mark Skousen pitched a SpaceX pre-IPO access code. A new Agora-family publisher called Grey Swan Fraternity pitched a $26 billion Pentagon defense contractor at roughly $20 a share. The Motley Fool pitched the company it said Netflix feared. The convergence is the signal: every publisher arrived at “get in before the IPO” independently within the same window, which means the underlying structural fact is real and the question worth asking is how that access actually works. The Anthropic, OpenAI, xAI IPO race is the backdrop; the SpaceX IPO thesis is the worked example.
The structural fact is that companies now stay private roughly a decade before going public, compared to about four years in 1999. The value created during those private years used to accrue to public-market investors who bought the IPO. It now accrues to private investors who bought before the IPO. The retail question is whether that private-stage access is still restricted to venture capitalists and institutions, and the answer is that it has opened up substantially since the 2012 JOBS Act rewrote the rules. There are four real paths, and the promos selling you one of them wrapped in a guru’s specific pick are usually selling the narrowest version of the four.
The closed-end fund path: buy a basket through your brokerage
The simplest path for a non-accredited retail investor is a publicly traded closed-end fund that holds private companies. You buy shares through any standard brokerage account, using the same process you would use to buy a public index fund. No accreditation, no $25,000 minimums, no platform-specific learning curve.
Destiny Tech100 (NYSE: DXYZ) is the dominant name in this category. It is a closed-end fund that holds roughly 20 to 25 private companies, and its largest positions as of the latest SEC-filed portfolio disclosure are Anthropic at approximately 18 percent, SpaceX at approximately 14.5 percent, OpenAI at roughly 5.8 percent, and a long tail including Shield AI, Databricks, and OpenEvidence. The fund’s net asset value per share was $19.97 as of December 31, 2025, and the NAV rose 209.59 percent during 2025, driven by revaluations of its private holdings.
The catch is the premium. DXYZ is a closed-end fund, which means its market price is set by supply and demand on the exchange, not by the underlying NAV. Through 2025 the market price return was negative 47.96 percent even as the NAV more than tripled, because the premium collapsed. An investor who bought DXYZ at a 100 percent premium to NAV was paying two dollars for every dollar of underlying private-company exposure, and when that premium compressed the underlying gains did not save the share price. The premium is the cost of liquidity and access, and it is the single most important variable to watch on any closed-end pre-IPO fund.
The ARK Venture Fund (ARKVX) is the second name. It is an interval fund, not exchange-traded, with a $500 minimum and a 1.75 percent annual management fee. Its holdings include SpaceX, Anthropic, OpenAI, and Databricks. The trade-off versus DXYZ is liquidity: ARKVX offers quarterly redemption windows only, meaning you can sell during scheduled periods rather than at will. The lower fee and lower minimum make it the more efficient vehicle for a buy-and-hold position; the quarterly liquidity makes it the wrong vehicle for anyone who might need to exit on short notice.
Neither fund requires accredited-investor status. Both are the closest thing to a one-click diversified pre-IPO portfolio for a retail buyer, and neither is mentioned in the guru promos because the promos sell a single named pick rather than a basket.
The IPO allocation path: open the right brokerage accounts
When a private company goes public, the lead underwriters reserve a portion of the IPO shares for retail investors. The allocation is distributed through specific brokerages that have agreements with the underwriters, and the process is closer to a lottery than a purchase. You need accounts at the right brokerages before the IPO window opens, and the allocation is typically 5 to 50 shares per account.
E*Trade, now part of Morgan Stanley, is the weighted-allocation platform for Morgan Stanley-led deals. A funded account with a meaningful balance gets a better allocation than a brand-new $100 account. Robinhood and SoFi run pure lottery allocations, where a small account has the same odds as a large one. Fidelity gets allocations on Goldman Sachs-led deals but requires $100,000 in household assets or 36 trades per year to qualify. Charles Schwab is mid-pack.
The realistic strategy is to hold funded accounts at three platforms before any IPO you care about. Three platforms means three independent lottery tickets per deal, and the realistic outcome on an oversubscribed IPO is that one or two of the three fill you for a small number of shares. The SpaceX IPO on June 12, 2026, was the test case: retail allocation was thin, the stock opened above the IPO price, and most lottery-account holders who got shares received fewer than 50.
This path is free to set up and costs nothing if you never get allocated. The constraint is that you only get shares at the IPO price if you get shares at all, and the most oversubscribed deals are the ones where retail allocation is smallest.
The secondary marketplace path: accredited only
For investors who meet the accredited standard, which the SEC defines as $200,000 in annual income individually or $300,000 jointly, or $1 million in net worth excluding a primary residence, the secondary marketplace is the direct path. These platforms connect existing shareholders, usually employees with vested shares, with buyers. The minimums run from $10,000 to $100,000 per position, and the shares are typically held through a special-purpose vehicle rather than transferred directly to the buyer.
The platforms that matter are Hiive, EquityZen, UpMarket, and Augment. Hiive operates an order book with transparent pricing across roughly 3,000 pre-IPO companies and is the easiest venue for watching real-time secondary-market pricing. EquityZen has the longest tenure and runs single-company funds with $20,000 typical minimums. Augment lists over 300 private companies with $10,000 minimums. All of them operate under Reg D Rule 506(c), which restricts participation to accredited investors.
The largest platform, Forge Global, was acquired by Charles Schwab in a deal that closed on March 2, 2026, at $45 per share in cash, and Forge was delisted from the NYSE. The platform now lives inside Schwab’s accredited-investor offering. That acquisition is the clearest signal that the major retail brokerages see the private secondary market as a growth channel and are positioning to bring it to a wider audience over time.
The honest caveat on secondaries is pricing. Shares on these platforms typically trade at a 20 to 40 percent premium to the company’s most recent primary funding round. Anthropic’s Series H priced the company at roughly $965 billion, and secondary buyers on these platforms were paying implied valuations above $1.1 trillion by mid-2026. That premium is the cost of buying access to a company that may not IPO for another year or two, and it means you are paying more per share than the institutional investors who bought in the last primary round.
The Reg CF and Reg A+ path: the JOBS Act back door
The fourth path is the one the promos most often reference without explaining. The 2012 JOBS Act directed the SEC to create exemptions that let non-accredited investors buy shares in private companies before they go public. Regulation Crowdfunding (Reg CF) lets companies raise up to $5 million per year through registered portals like Republic, StartEngine, and Wefunder, with minimums that can be under $50. Regulation A+ Tier 2 lets companies raise up to $75 million per year, with non-accredited investors capped at 10 percent of the greater of their income or net worth.
The worked example was rAnthropic, a Reg CF offering on Republic that closed in March 2026 and raised $1.5 million from 1,314 investors at under $50 per entry. The mechanism is real and the SEC rules are real. The complications are also real and are covered in the full Reg CF walkthrough, so the short version here is: every Reg CF purchase carries a one-year resale lockup from your purchase date, the $5 million annual cap means Reg CF is pocket change for a company like Anthropic, and the largest companies actively resist tokenized structures that bypass their transfer restrictions. Reg CF is the narrowest of the four paths by dollar volume, and it is the path most often wrapped into a guru pitch as a “secret” the guru discovered.
What the promos do not tell you
The four paths exist independently of any guru. The Securities and Exchange Commission created them. The brokerages built the allocation infrastructure. The closed-end fund managers raised the capital and did the private-market sourcing. The secondary marketplaces built the platforms and the compliance rails. A promo that sells you a “backdoor” to a private company is usually selling one of these four mechanisms wrapped around a specific pick, and the mechanism is available without the guru’s report.
The structural risk the promos minimize is timing. The 1999 IPO window is the parallel that matters. The average technology company went public after four years, retail investors chased IPO allocation through newly opened Schwab and E*Trade accounts, and the access mechanism was real. Most of the 1999 IPOs were trading below their issue price within 18 months. The companies that survived, which included Amazon and Google, delivered returns that made the early investors wealthy, and the companies that did not survive, which was most of them, delivered the opposite. The access mechanism was never the variable that determined the return. The entry price and the underlying business were the variables, and the access mechanism just determined which price you paid.
The pre-IPO market in 2026 carries that pattern at a longer time scale. The companies stay private longer, the premiums on closed-end funds and secondary marketplaces are the new version of the IPO-pop-then-crash risk, and the access mechanism is real without being the point. The point is whether the underlying company is worth what you are paying for it, and the access mechanism just determines what you pay.
Where this leaves you
The pre-IPO door is open wider for retail investors than it has ever been. DXYZ and ARKVX let you buy a basket of private companies through a standard brokerage account. The IPO allocation path costs nothing to set up and pays off when a deal lands. The secondary marketplaces serve accredited investors who want a specific name. Reg CF and Reg A+ let non-accredited investors buy into specific offerings with under $50 minimums, subject to the limits and lockups the SEC wrote into the rules.
The smartest approach is to understand the infrastructure before you evaluate any promo selling you one piece of it. The four paths are the menu. A guru’s pick is one item on the menu, and the promo’s job is to make that one item feel like the only item. The infrastructure is the context that makes the pitch evaluable instead of urgent.
The access is real, and the pick is a separate question. The mechanism does not answer the question of whether the underlying company is worth the price the mechanism charges you to reach it.